Litcius/Paper detail

Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry

Tomohiro Tanaka, Ren Nanamiya, Junko Takei, Takuro Nakamura, Miyuki Yanaka, Hideki Hosono, Masato Sano, Teizo Asano, Mika K. Kaneko, Yukinari Kato

2021Monoclonal Antibodies in Immunodiagnosis and Immunotherapy52 citationsDOI

Abstract

CC chemokine receptor 8 (CCR8) belongs to the class A of G protein-coupled receptor. It is highly expressed on Treg and T helper 2 (T H 2) cells recruited to the inflammation site and is implicated in allergy and asthma. Recently, CCR8+Treg cells have been suggested to be a master regulator in the immunosuppressive tumor microenvironment; therefore, developing sensitive monoclonal antibodies (mAbs) for CCR8 has been desired. This study established a specific and sensitive mAb for mouse CCR8 (mCCR8), which is useful for flow cytometry by using the Cell-Based Immunization and Screening (CBIS) method. The established anti-mCCR8 mAb, C 8 Mab-2 (rat IgG 2b , kappa), reacted with mCCR8-overexpressed Chinese hamster ovary-K1 (CHO/mCCR8) cells and P388 (mouse lymphoid neoplasma) or J774-1 (mouse macrophage-like) cells, which express endogenous mCCR8 by flow cytometry. C 8 Mab-2, which was established by the CBIS method, could be useful for elucidating the mCCR8-related biological response by flow cytometry.

Topics & Concepts

Monoclonal antibodyFlow cytometryBiologyChemokine receptorImmunologyAntibodyMolecular biologyChemokineCCL22InflammationT-cell and B-cell ImmunologyImmune Cell Function and InteractionImmunotherapy and Immune Responses
Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry | Litcius